Process for preparing surface modification substances

• US 6,461,665 B1
• Filed: 02/28/2001
• Issued: 10/08/2002
• Est. Priority Date: 09/09/1998
• Status: Expired due to Term

• Current Assignee: Carmeda AB
• Original Assignee: Carmeda AB
• Inventors: Scholander, Elisabeth
• Primary Examiner(s): Beck, Shrive P.
• Assistant Examiner(s): Michener, Jennifer Kolb
• Application Number:
  US09/763,873
• Time in Patent Office: 587 Days
• Field of Search: 427/2.24, 427/2.25, 427/2.28, 427/2.3, 427/2.31, 427/301, 427/407.1, 427/409, 623/1.1, 623/1.43, 623/1.44, 623/1.45, 623/1.46
• US Class Current: 427/2.24
• CPC Class Codes: A61L 33/0029 using an intermediate layer of polymer
• CPC Class Codes: C08B 37/0075 Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Abstract

The present invention relates to a process for preparing surface modifications having an improved antithrombogenic activity, whereby the improvement is achieved by treating heparin at a temperature above 40° C. or a pH in the rage of 9-14 or in contact with nucleophilic catalysts before attaching said heparin to the surface to be modified.

Claims

1. A method for producing a substrate surface modification having an improved non-thrombogenic activity comprising at least the step of reacting:

(A) functional groups on a surface to be rendered non-thrombogenic, with

(B) heparin, modified to contain complementary functional groups, so as to form covalent bonds,

wherein said heparin is activated to enhance its activity when surface bound, in a step before reacting (A) with (B), through a procedure selected from the group consisting of;

(i) heating in a solvent in the range from 40°

C. to the boiling temperature of the solvent;

(ii) treatment at a pH in the range of 9-14; and

(iii) treatment with at least one nucleophilic catalyst.

2. A method according to claim 1, where the surface to be modified is treated in one or more steps to form a layer comprising functional groups on the surface.

3. A method according to claim 1, where the pH is in the range 9-11.

4. A method according to claim 3, where the pH is 10.

5. A method according to claim 1, where the nucleophilic catalyst is ammonium acetate.

6. A method according to claim 1, where the nucleophilic catalyst contains immobilized amino-groups.

7. A method according to claim 2, which comprises forming a layer on the surface by:

(A);

(a) adding a layer of a polymer comprising amino groups to the surface to be modified,

(b) optionally cross-linking the layer of step (a) with a bifunctional cross-linking agent,

(c) adding a layer of an anionic polymer to the layer of step (b),

(d) optionally repeating the steps (a), (b) and (c) at least one time,

(e) followed by a final step (a), and

(B);

(f) modifying heparin through nitrous acid or periodate oxidation to comprise aldehyde groups,

(g) activating the aldehyde containing heparin in a further step to enhance its activity when surface bound, said activating step (g) being selected from the group consisting of;

(i) heating in a solvent in the range from 40°

C. to the boiling temperature of the solvent;

(ii) treatment at a pH in the range of pH 9-14; and

(iii) treatment with at least one nucleophilic catalyst, and finally

(h) reacting the layer resulting from step (a) or (e) with the further treated aldehyde heparin from step (g).

8. A surface modified substrate produced according to claim 2.

9. A method according to claim 2, which comprises forming a layer on the surface by

(A):

(a) adding a layer of a polymer comprising amino groups to the surface to be modified,

(b) optionally cross-linking the layer of step (a) with a bifunctional cross-linking agent,

c) adding a layer of an anionic polymer to the layer of step (b),

(d) optionally repeating the steps (a), (b) and (c) at least one time,

(e) followed by a final step (a), and

(B);

(f) modifying heparin through nitrous acid or periodate oxidation to comprise aldehyde groups,

(g) activating the aldehyde containing heparin in a further step to enhance its activity when surface bound, said activating step (g) being selected from the group consisting of;

(i) treatment at a pH in the range of pH 9-14;

(ii) treatment with at least one nucleophilic catalyst; and

(iii) heating in the range from 40°

C. to the boiling temperature of the solvent in combination with step (i) and/or step (ii).

10. A method for producing a substrate surface modification having an improved non-thrombogenic activity comprising at least the step of reacting

(A) functional groups on a surface to be rendered non-thrombogenic, with

(B) heparin, modified to contain complementary functional groups, so as to form covalent bonds, wherein said heparin is activated to enhance its activity when surface bound, in a step before reacting (A) with (B), through a procedure selected from the group consisting of:

(i) treatment at a pH in the range of pH 9-14;

(ii) treatment with at least one nucleophilic catalyst; and

(iii) heating in the range from 40°

C. to the boiling temperature of the solvent in combination with step (i) and/or step (ii).